LOSA, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 4.659
AS - Asia 4.543
EU - Europa 4.035
SA - Sud America 954
Continente sconosciuto - Info sul continente non disponibili 253
AF - Africa 80
OC - Oceania 9
Totale 14.533
Nazione #
US - Stati Uniti d'America 4.463
RU - Federazione Russa 2.373
SG - Singapore 1.608
CN - Cina 1.479
BR - Brasile 780
HK - Hong Kong 572
SE - Svezia 496
IT - Italia 421
VN - Vietnam 375
FR - Francia 210
DE - Germania 128
BD - Bangladesh 119
GB - Regno Unito 116
IN - India 105
CA - Canada 90
AR - Argentina 75
IE - Irlanda 68
MX - Messico 55
PL - Polonia 38
JP - Giappone 35
AT - Austria 34
ID - Indonesia 34
FI - Finlandia 33
NL - Olanda 27
EC - Ecuador 26
ZA - Sudafrica 25
TR - Turchia 24
MY - Malesia 22
IQ - Iraq 20
VE - Venezuela 20
EG - Egitto 17
ES - Italia 17
MA - Marocco 17
PH - Filippine 17
SA - Arabia Saudita 17
UA - Ucraina 15
CO - Colombia 14
JM - Giamaica 14
UZ - Uzbekistan 14
PK - Pakistan 13
CL - Cile 12
AE - Emirati Arabi Uniti 11
LT - Lituania 10
PY - Paraguay 10
KZ - Kazakistan 8
MD - Moldavia 8
AU - Australia 7
CR - Costa Rica 7
IR - Iran 7
PE - Perù 7
AZ - Azerbaigian 6
HN - Honduras 6
LB - Libano 6
NP - Nepal 6
TN - Tunisia 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
KE - Kenya 5
TH - Thailandia 5
XK - ???statistics.table.value.countryCode.XK??? 5
HU - Ungheria 4
IL - Israele 4
JO - Giordania 4
NI - Nicaragua 4
PS - Palestinian Territory 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
CH - Svizzera 3
CY - Cipro 3
CZ - Repubblica Ceca 3
GR - Grecia 3
KG - Kirghizistan 3
NO - Norvegia 3
OM - Oman 3
TT - Trinidad e Tobago 3
BE - Belgio 2
BG - Bulgaria 2
BH - Bahrain 2
KR - Corea 2
LC - Santa Lucia 2
LV - Lettonia 2
MO - Macao, regione amministrativa speciale della Cina 2
MT - Malta 2
NG - Nigeria 2
PA - Panama 2
QA - Qatar 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AW - Aruba 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DZ - Algeria 1
Totale 14.265
Città #
Singapore 738
Moscow 586
Hong Kong 563
Ashburn 501
Council Bluffs 469
San Jose 427
Dallas 398
Shanghai 287
The Dalles 230
North Charleston 204
Hefei 202
Beijing 184
Lawrence 168
Princeton 168
Lauterbourg 165
New York 158
Ho Chi Minh City 131
Santa Clara 106
Milan 105
Los Angeles 95
Hanoi 87
São Paulo 73
Dublin 68
Munich 50
Las Vegas 48
Rome 40
Orem 36
Atlanta 32
Warsaw 32
Phoenix 29
Seattle 29
Tokyo 29
Chennai 26
Haiphong 26
Rio de Janeiro 26
Boardman 25
Chicago 25
Waynesboro 24
London 23
Nuremberg 23
Washington 23
Boston 22
Denver 21
Houston 21
Manchester 21
Toronto 21
Mexico City 20
Brooklyn 19
Guangzhou 18
Helsinki 18
Montreal 18
San Francisco 18
Curitiba 17
Poplar 17
Belo Horizonte 16
Bologna 16
Frankfurt am Main 16
Brasília 14
Columbus 14
Kuala Lumpur 14
Stockholm 14
Turku 14
Amsterdam 13
Cairo 13
Campinas 13
Da Nang 13
Johannesburg 13
Mumbai 13
Pune 13
Tashkent 13
Vienna 13
Naples 12
Buffalo 11
Philadelphia 11
Porto Alegre 10
Riyadh 10
Shenzhen 10
Casablanca 9
Cesano Boscone 9
Guayaquil 9
Hải Dương 9
Querétaro 9
Salvador 9
Ankara 8
Barnet 8
Caracas 8
Charlottesville 8
Dhaka 8
Guarulhos 8
Hangzhou 8
Miami 8
Quito 8
Ribeirão Preto 8
Santiago 8
Turin 8
Biên Hòa 7
Calgary 7
Contagem 7
Hanover 7
Medellín 7
Totale 7.394
Nome #
Cushing's disease due to double pituitary ACTH-secreting adenomas: The first case report 825
Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas 334
Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo 238
Pituitary Surgery 177
A consensus on the diagnosis and treatment of acromegaly comorbidities: An update 142
Craniopharyngioma 138
Asymptomatic Thyrotropin-secreting Pituitary Macroadenoma in a Thirteen Year-old Girl: Successful First-line Treatment with Somatostatin Analogues 136
Acromegaly associated with a granular cell tumor of the neurohypophysis: a clinical and histological study - Case report 133
Gamma knife radiosurgery in patients with Nelson’s syndrome 130
Benign and Malignant Tumors of the Pituitary Gland 128
Craniopharyngiomas 116
A non-functioning pituitary adenoma initially mimicking a microprolactinoma: The case for long-term follow-up of patients with mild hyperprolactinemia? 116
Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature 114
A Multicenter, Propensity Score–Matched Assessment of Endoscopic Versus Microscopic Approaches in the Management of Pituitary Adenomas 113
Novel approach to bone comorbidity in resistant acromegaly 113
Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly 108
High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly 107
Acromegaly: surgical results and prognosis. 106
Gamma knife radiosurgery for pituitary tumors: A systematic review and meta‐analysis 103
Comparison between extended transsphenoidal and transcranial surgery for craniopharyngioma: focus on hypothalamic function and obesity 103
AZA-Deoxycytidine stimulates proopiomelanocortin gene expression and ACTH secretion in human pituitary ACTH-secreting tumors 101
Bacterial endotoxin (Lipopolysaccharide) stimulates interleukin-6 production and inhibits growth of pituitary tumour cells expressing the Toll-like receptor 4 101
Crooke Cell Adenoma Confers Poorer Endocrinological Outcomes Compared with Corticotroph Adenoma: Results of a Multicenter, International Analysis 100
High prevalence of adrenal cortical adenomas in patients with cerebral meningiomas 98
Acromegaly is associated with increased cancer risk: A survey in Italy 98
Intranasal oxytocin as a treatment for obesity: safety and efficacy 97
Normal insulin-like growth factor 1 during somatostatin receptor ligand treatment predicts surgical cure in acromegaly 94
Craniopharyngioma in Pediatrics and Adults 93
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma 93
Bone morphogenetic protein-4 inhibits corticotroph tumor cells: Involvement in the retinoic acid inhibitory action 89
Primary sellar melanocytoma: report of two cases treated at the same institution and their long-term outcome 89
Bone and body composition analyses by DXA in adults with GH deficiency: effects of long-term replacement therapy 87
A conformational switch controlling the toxicity of the prion protein 86
The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): A surgical perspective 86
Bilateral inferior petrosal sinus sampling in adrenocorticotropin-dependent hypercortisolism: always, never, or sometimes? 86
Erratum: Time course of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors (Radiotherapy and Oncology 99 (2011) (23-28)) 85
Microsurgical therapy of pituitary adenomas 85
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study 85
Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS) 84
Pituitary radiotherapy for Cushing's disease 84
Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing's syndrome: results from a retrospective multicenter study 83
The open sella technique for surgical treatment of pituitary macroadenomas: Safety and efficacy in a large clinical series 83
Ubiquitin-Specific Protease 8 Mutant Corticotrope Adenomas Present Unique Secretory and Molecular Features and Shed Light on the Role of Ubiquitylation on ACTH Processing 82
Resistance to first-generation somatostatin receptor ligands does not impair the results of gamma knife radiosurgery in acromegaly 81
The role of surgical management for prolactin-secreting tumors in the era of dopaminergic agonists: An international multicenter report 80
Repeat gamma knife radiosurgery for recurrent pituitary adenomas. 80
Widened transnasal surgical approach for removal of huge, forward-spreading pituitary neoplasms 80
Desmopressin stimulation test before and after pituitary surgery in patients with Cushing's disease 79
D3-Growth hormone receptor polymorphism in acromegaly: Effects on metabolic phenotype 78
Complications of transsphenoidal surgery in patients with pituitary adenoma: experience at a single centre 77
Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement 77
Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series 76
Role of radiosurgery in the treatment of Cushing's disease 75
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients 74
Treatment of empty sella associated with visual impairment: a systematic review of chiasmapexy techniques 74
Letter to the Editor. Management of residual nonfunctioning pituitary adenoma: watchful waiting or adjuvant treatment? 73
Indium-111 pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: correlation with the effect of a single administration of octreotide on serum TSH levels RID B-6543-2008 73
Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas RID B-6543-2008 73
Asymptomatic internal carotid artery occlusion after gamma knife radiosurgery for pituitary adenoma: Report of two cases and review of the literature 72
Endocrine inactive and gonadotroph adenomas: diagnosis and management 71
Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases. 70
Surgical treatment of prolactin-secreting pituitary adenomas: Early results and long-term outcome 70
Food intake regulating hormones in adult craniopharyngioma patients 70
Metastatic prostatic adenocarcinoma presenting as a pituitary mass: Shrinkage of the lesion and clinical improvement with medical treatment 69
Combined insulin resistance of glucose and protein metabolism in acromegaly 69
Dosimetric factors associated with pituitary function after Gamma Knife Surgery (GKS) of pituitary adenomas. 69
IL-23 secreted by myeloid cells drives castration-resistant prostate cancer 69
Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors 68
The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas 68
First-line therapy of acromegaly: A statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group 68
Proliferation index of nonfunctioning pituitary adenomas: Correlations with clinical characteristics and long-term follow-up results 67
Frequency, pattern, and outcome of recurrences after gamma knife radiosurgery for pituitary adenomas 67
Coexistence of TSH-secreting pituitary adenoma and autoimmune hypothyroidism 67
Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors - Comparison between micro- and macroadenomas 67
Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing's disease. 67
Time course of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors 67
Increased insulin-stimulated endothelin-1 release is a distinct vascular phenotype distinguishing Cushing's disease from metabolic syndrome 67
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients 67
Corticotroph tumor progression after bilateral adrenalectomy (Nelson’s syndrome): systematic review and expert consensus recommendations 66
Combined insulin resistance of glucose and protein metabolism in acromegaly. 65
Pros and cons in endocrine practice: pre-surgical treatment with somatostatin analogues in acromegaly 65
Non-functioning pituitary adenoma database: A useful resource to improve the clinical management of pituitary tumors 65
Surgical approach to craniopharyngiomas: transcranial routes 65
Hypokalemic periodic paralysis in a patient with acquired growth hormone deficiency 64
Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone secretion and cell growth in cultured GH-secreting pituitary tumor cells 64
Ovarian hyperstimulation syndrome due to follicle-stimulating hormone-secreting pituitary adenomas 64
Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma 64
Predictors of morbidity and mortality in acromegaly: An Italian survey 64
Clinical characteristics and surgical outcome in USP8-mutated human adrenocorticotropic hormone-secreting pituitary adenomas 64
Long-term effects of growth hormone replacement therapy on thyroid function in adults with growth hormone deficiency 63
Longitudinal splitting of optic pathways by non-functioning pituitary macroadenoma: report of two cases. 62
Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas 62
Differentiation of clinically non-functioning pituitary adenomas from meningiomas and craniopharyngiomas by positron emission tomography with [F-18]fluoro-ethyl-spiperone RID C-6773-2008 62
Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy 62
Solitary clival plasmocytomas: Misleading clinical and radiological features of a rare pathology with a specific biological behaviour. 62
Treatment of aggressive pituitary tumours and carcinomas: Results of a European Society of Endocrinology (ESE) survey 2016 62
Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS) 62
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas 62
Surgery followed by gamma knife radiosurgery for treatment of acromegaly 61
Primary sellar melanocytoma: pathological, clinical and treatment review 61
Totale 9.459
Categoria #
all - tutte 87.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.741


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202286 0 0 0 49 7 1 13 3 1 2 1 9
2022/2023939 364 169 87 39 10 100 70 74 20 2 1 3
2023/2024491 18 5 40 37 46 140 6 39 3 17 26 114
2024/20252.492 359 62 15 77 68 234 371 163 418 312 187 226
2025/20269.168 602 786 734 1.122 557 790 820 563 2.155 456 288 295
2026/20271.189 466 723 0 0 0 0 0 0 0 0 0 0
Totale 14.533